Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,793 | -39,222 | -2,085 | 2,453 | 9,095 |
| Depreciation Amortization | 19 | 78 | 58 | 39 | 19 |
| Accounts payable and accrued liabilities | 539 | -4,968 | -3,385 | -2,003 | -3,473 |
| Other Working Capital | 1,320 | -6,941 | -5,841 | -5,273 | -5,810 |
| Other Operating Activity | 7,279 | 33,745 | -1,343 | -5,216 | -7,740 |
| Operating Cash Flow | $-2,636 | $-17,308 | $-12,596 | $-10,000 | $-7,909 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -4 | -4 | -4 | -4 |
| Investing Cash Flow | $0 | $-4 | $-4 | $-4 | $-4 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,208 | N/A | N/A | 0 | N/A |
| Common Stock Issued | 1,665 | 18,514 | 18,514 | 18,430 | 18,346 |
| Other Financing Activity | 0 | 1,791 | 0 | 0 | 0 |
| Financing Cash Flow | $5,873 | $20,305 | $18,514 | $18,430 | $18,346 |
| Beginning Cash Position | 3,006 | 13 | 13 | 13 | 13 |
| End Cash Position | 6,243 | 3,006 | 5,927 | 8,439 | 10,446 |
| Net Cash Flow | $3,237 | $2,993 | $5,914 | $8,426 | $10,433 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,636 | -17,308 | -12,596 | -10,000 | -7,909 |
| Capital Expenditure | 0 | -4 | -4 | -4 | -4 |
| Free Cash Flow | -2,636 | -17,312 | -12,600 | -10,004 | -7,913 |